These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10148476)
1. Use of genetic information by private insurers. Genetic advances: the perspective of an insurance medical director. Pokorski RJ J Insur Med; 1992; 24(1):60-8. PubMed ID: 10148476 [No Abstract] [Full Text] [Related]
2. Genetic testing in insurance underwriting: a blessing or a curse? An examination of the tension between economics and equity in using genetic testing in risk classification. Anderson MC Creighton Law Rev; 1992 Jun; 25(4):1499-535. PubMed ID: 11654461 [No Abstract] [Full Text] [Related]
3. Common themes among different types of insurance. Pyeritz RE Birth Defects Orig Artic Ser; 1990; 26(2):121-7. PubMed ID: 2151251 [No Abstract] [Full Text] [Related]
4. Genetic information and life insurance. Pokorski RJ Nature; 1995 Jul; 376(6535):13-4. PubMed ID: 7596420 [TBL] [Abstract][Full Text] [Related]
5. Is genetic information relevantly different from other kinds of non-genetic information in the life insurance context? Malpas PJ J Med Ethics; 2008 Jul; 34(7):548-51. PubMed ID: 18591292 [TBL] [Abstract][Full Text] [Related]
7. The use of genetic information for nonmedical purposes. Rothstein MA J Law Health; 1994-1995; 9(1):109-20. PubMed ID: 11654452 [No Abstract] [Full Text] [Related]
8. The likely financial effects on individuals, industry and commerce of the use of genetic information. Ross T Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1103-6. PubMed ID: 9304677 [TBL] [Abstract][Full Text] [Related]
9. On defining the genetic test. Chambers DC J Insur Med; 1995-1996 Winter; 27(3):198-203. PubMed ID: 10160222 [No Abstract] [Full Text] [Related]
10. Genetic screening and the insurance industry. Pokorski R Yale J Biol Med; 1991; 64(1):53-7. PubMed ID: 1897262 [No Abstract] [Full Text] [Related]
11. Genetic testing and insurance. Bodmer W Nature; 1996 Apr; 380(6573):384-6. PubMed ID: 8602232 [No Abstract] [Full Text] [Related]
12. How will improved forecasts of individual lifetimes affect underwriting? MacDonald AS Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1067-75. PubMed ID: 9304673 [TBL] [Abstract][Full Text] [Related]
13. Genetic Catch-22: testing, risk and private health insurance. Hedgecoe A Bus Prof Ethics J; 1996; 15(2):69-86. PubMed ID: 11655327 [No Abstract] [Full Text] [Related]
14. The challenges of genetic advances. Weiland AJ Healthplan; 2000; 41(6):24-30. PubMed ID: 11185806 [No Abstract] [Full Text] [Related]
15. The use of genetic testing in the health insurance industry: the creation of a "biologic underclass". O'Hara S Southwest Univ Law Rev; 1993; 22(4):1211-28. PubMed ID: 11659756 [No Abstract] [Full Text] [Related]
16. Public policy and legal issues raised by advances in genetic screening and testing. Reilly PR Suffolk Univ Law Rev; 1993; 27(4):1327-57. PubMed ID: 11657041 [No Abstract] [Full Text] [Related]
17. Genetic screening of adolescents. Spiegler GE N Engl J Med; 1997 Aug; 337(9):639-40. PubMed ID: 9280838 [No Abstract] [Full Text] [Related]
18. Participation in pedigree studies and the risk of impeded access to health insurance. Kass NE IRB; 1993; 15(5):7-10. PubMed ID: 11659704 [No Abstract] [Full Text] [Related]
19. Time for reassessment of use of all medical information by UK insurers. Thomson B Lancet; 1998 Oct; 352(9135):1216-8. PubMed ID: 9777856 [No Abstract] [Full Text] [Related]
20. Genetic information and life insurance: a 'real' risk? Joly Y; Knoppers BM; Godard B Eur J Hum Genet; 2003 Aug; 11(8):561-4. PubMed ID: 12891375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]